ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
941.00
-33.00 (-3.39%)
At close: Apr 20, 2026

KOSDAQ:034940 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,3252,0972,0474,5265,749
Short-Term Investments
198.122,5491,5381,5371,587
Trading Asset Securities
-800.73775.022,3862,849
Cash & Short-Term Investments
2,5235,4474,3618,44910,184
Cash Growth
-53.69%24.93%-48.39%-17.04%12.59%
Accounts Receivable
17,80818,25020,23022,72720,884
Other Receivables
1,6711,8182,5932,7312,359
Receivables
19,92320,94823,90027,60324,867
Inventory
11,71712,44613,01210,86910,286
Prepaid Expenses
96.25204.8887.4594.42118.8
Other Current Assets
792.76693.01796.441,1831,048
Total Current Assets
35,05239,74042,15748,20046,504
Property, Plant & Equipment
19,06719,71220,37024,99924,074
Long-Term Investments
3,5343,0682,7922,9353,678
Goodwill
----46.78
Other Intangible Assets
549.56769803.4806.87795.5
Long-Term Accounts Receivable
-01,0541,054-
Long-Term Deferred Tax Assets
365.471,3701,4991,401945.32
Other Long-Term Assets
5,9166,6625,5446,0284,049
Total Assets
64,68371,32074,22185,63980,512
Accounts Payable
3,4864,8655,5014,9943,685
Accrued Expenses
3,0803,5163,4942,7652,775
Short-Term Debt
22,10520,75014,55014,55412,794
Current Portion of Long-Term Debt
905.51448.61---
Current Portion of Leases
564.54629.07633.15637.5684.07
Current Unearned Revenue
73.84140.5153.42122.2788.1
Other Current Liabilities
5,5456,3064,8474,2554,236
Total Current Liabilities
35,75936,65629,17827,32824,263
Long-Term Debt
1,9731,5761,1051,9041,000
Long-Term Leases
1,7571,2851,2131,5831,996
Pension & Post-Retirement Benefits
1,4351,301545.82-1,328
Other Long-Term Liabilities
1,9911,9413,4223,4173,542
Total Liabilities
42,91642,75935,46434,23132,129
Common Stock
15,49015,49015,49015,49015,490
Additional Paid-In Capital
63,62163,62163,62163,62163,621
Retained Earnings
-54,180-47,817-38,175-26,354-29,255
Comprehensive Income & Other
74.0281.6757.0786.2964.05
Total Common Equity
25,00531,37640,99352,84449,920
Minority Interest
-3,239-2,815-2,235-1,436-1,537
Shareholders' Equity
21,76728,56138,75851,40848,383
Total Liabilities & Equity
64,68371,32074,22185,63980,512
Total Debt
27,30524,68917,50118,67816,474
Net Cash (Debt)
-24,782-19,242-13,141-10,229-6,289
Net Cash Per Share
-801.10-621.05-424.17-330.17-203.02
Filing Date Shares Outstanding
30.830.9830.9830.9830.98
Total Common Shares Outstanding
30.830.9830.9830.9830.98
Working Capital
-707.593,08412,97920,87222,242
Book Value Per Share
811.811012.781323.221705.751611.38
Tangible Book Value
24,45630,60740,19052,03749,078
Tangible Book Value Per Share
793.97987.961297.291679.701584.20
Land
8,8118,8118,8649,4089,329
Buildings
14,61514,75614,73918,17818,129
Machinery
30,79530,69330,23326,89326,807
Construction In Progress
508.12-7.244,1571,430
Source: S&P Global Market Intelligence. Standard template. Financial Sources.